$154.02
0.43% day before yesterday
Nasdaq, Jan 02, 10:00 pm CET
ISIN
US0576652004
Symbol
BCPC

Balchem Corporation Stock price

$154.02
-0.08 0.05% 1M
-9.18 5.63% 6M
+0.66 0.43% YTD
-4.56 2.88% 1Y
+31.91 26.13% 3Y
+38.68 33.54% 5Y
+95.90 165.00% 10Y
+145.19 1,643.77% 20Y
Nasdaq, Closing price Fri, Jan 02 2026
+0.66 0.43%
ISIN
US0576652004
Symbol
BCPC
Sector
Industry

New AI Insights on Balchem Corporation Insights AI Insights on Balchem Corporation

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$5.0b
Enterprise Value
$5.1b
Net debt
$90.7m
Cash
$65.1m
Shares outstanding
32.4m
Valuation (TTM | estimate)
P/E
33.8 | 29.6
P/S
4.9 | 4.7
EV/Sales
5.0 | 4.8
EV/FCF
31.4
P/B
3.8
Dividends
DPS
$0.96
Yield 1Y | 5Y
0.6% | 0.6%
Growth 1Y | 5Y
10.3% | 10.6%
Payout 1Y | 3Y
22.1% | 22.5%
Increased
16 Years
Financials (TTM | estimate)
Revenue
$1.0b | $1.1b
EBITDA
$249.4m | $279.7m
EBIT
$204.5m | $226.5m
Net Income
$149.2m | $168.8m
Free Cash Flow
$161.6m
Growth (TTM | estimate)
Revenue
7.6% | 10.4%
EBITDA
11.3% | 20.6%
EBIT
18.2% | 23.1%
Net Income
22.8% | 31.4%
Free Cash Flow
-0.6%
Margin (TTM | estimate)
Gross
35.8%
EBITDA
24.6% | 26.6%
EBIT
20.2%
Net
14.7% | 16.0%
Free Cash Flow
15.9%
Financial Health
Equity Ratio
73.0%
Return on Equity
11.2%
ROCE
13.3%
ROIC
10.2%
Debt/Equity
0.1
More
EPS
$4.6
FCF per Share
$5.0
Short interest
1.8%
Employees
1k
Rev per Employee
$690.0k
Show more

Is Balchem Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

Balchem Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Balchem Corporation forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Balchem Corporation forecast:

Buy
88%
Hold
13%

Financial data from Balchem Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
1,014 1,014
8% 8%
100%
- Direct Costs 650 650
5% 5%
64%
363 363
12% 12%
36%
- Selling and Administrative Expenses 140 140
3% 3%
14%
- Research and Development Expense 18 18
11% 11%
2%
249 249
11% 11%
25%
- Depreciation and Amortization 45 45
12% 12%
4%
EBIT (Operating Income) EBIT 204 204
18% 18%
20%
Net Profit 149 149
23% 23%
15%

In millions USD.

Don't miss a Thing! We will send you all news about Balchem Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Balchem Corporation Stock News

Neutral
Seeking Alpha
7 days ago
Chevron (CVX) is expected to extend its dividend growth streak to 39 years, but with a muted 3–4% increase amid lower oil prices. CVX's earnings remain under pressure from declining oil prices despite cost-saving initiatives and the Hess acquisition, leading to subdued dividend growth. Dividend increases in January will generally be modest, with select companies like Fastenal, S&P Global, and C...
Neutral
GlobeNewsWire
12 days ago
MONTVALE, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) -- As producers of choline chloride in the EU, Eastman and Balchem welcome the European Union's decision published on December 19, 2025 to adopt anti-dumping duties between 90.0 and 115.9% on choline chloride imports from the People's Republic of China.
Neutral
The Motley Fool
22 days ago
David B Fischer directly sold 8,000 shares for a total of ~$1,231,748 on Dec. 3, 2025, at a weighted average price of around $154 per share. This transaction reduced his direct holdings by 50%, leaving him with 7,989 shares.
More Balchem Corporation News

Company Profile

marketing of specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health, Specialty Products and Industrial Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems. The Animal Nutrition and Health segment comprises nutritional products derived from microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment offers Ethylene oxide for the health care industry. The Industrial Products segment refers to certain derivatives of choline chloride which manufactured and sold into industrial applications as a component for hydraulic fracturing of shale natural gas wells. The company was founded in January 1967 and is headquartered in New Hampton, NY.

Head office United States
CEO Theodore Harris
Employees 1,379
Founded 1967
Website balchem.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today